The Role of Chemokine Receptors in HIV Infection of Host Cells

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 191-196

  Reeves, Jacqueline D ^a   Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943227304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50393-4     Document Type: Chapter

References (61)

1. F. Barre-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum and L. Montagnier (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 868-871.
2. F. Clavel, D. Guetard, F. Brun-Vezinet, S. Chamaret, M.A. Rey, M.O. Santos-Ferreira, A.G. Laurent, C. Dauguet, C. Katlama, C. Rouzioux, D. Klatzmann, J.L. Champalimaud and L. Montagnier (1986) Isolation of a new human retrovirus from West African patients with AIDS. Science 233 343-346.
3. E.A. Berger, R.W. Doms, E.M. Fenyo, B.T. Korber, D.R. Littman, J.P. Moore, Q.J. Sattentau, H. Schuitemaker, J. Sodroski and R.A. Weiss (1998) A new classification for HIV-1. Nature 391 240.
4. J.M. McCune, L.B. Rabin, M.B. Feinberg, M. Lieberman, J.C. Kosek, G.R. Reyes and I.L. Weissman (1988) Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53 55-67.
5. G.B. Melikyan, R.M. Markosyan, H. Hemmati, M.K. Delmedico, D.M. Lambert and F.S. Cohen (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 151 413-423.
6. R.I. Connor, K.E. Sheridan, D. Ceradini, S. Choe and N.R. Landau (1997) Change in coreceptor use coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185 621-628.
7. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N.R. Landau, J. Phair, D.D. Ho and R.A. Koup (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2 1240-1243.
8. A.M. de Roda Husman, R.P. van Rij, H. Blaak, S. Broersen and H. Schuitemaker (1999) Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression. J. Infect. Dis. 180 1106-1115.
9. S. Li, J. Juarez, M. Alali, D. Dwyer, R. Collman, A. Cunningham and H.M. Naif (1999) Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73 9741-9755.
10. A.B. van't Wout, L.J. Ran, C.L. Kuiken, N.A. Kootstra, S.T. Pals and H. Schuitemaker (1998) Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72 488-496.
11. M. Tersmette, R.E. de Goede, B.J. Al, I.N. Winkel, R.A. Gruters, H.T. Cuypers, H.G. Huisman and F. Miedema (1988) Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62 2026-2032.
12. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels and S.J. O'Brien (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 1856-1862.
13. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup and N.R. Landau (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 367-377.
14. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R.J. Smyth, R.G. Collman, R.W. Doms, G. Vassart and M. Parmentier (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 722-725.
15. C. Balotta, P. Bagnarelli, M. Violin, A.L. Ridolfo, D. Zhou, A. Berlusconi, S. Corvasce, M. Corbellino, M. Clementi, M. Clerici, M. Moroni and M. Galli (1997) Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11 F67-F71.
16. R. Biti, R. Ffrench, J. Young, B. Bennetts, G. Stewart and T. Liang (1997) HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3 252-253.
17. H. Heiken, S. Becker, I. Bastisch and R.E. Schmidt (1999) HIV-1 infection in a heterosexual man homozygous for CCR-5 delta32. AIDS 13 529-530.
18. N.L. Michael, J.A. Nelson, V.N. KewalRamani, G. Chang, S.J. O'Brien, J.R. Mascola, B. Volsky, M. Louder, G.C. White 2nd, D.R. Littman, R. Swanstrom and T.R. O'Brien (1998) Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J. Virol. 72 6040-6047.
19. T.R. O'Brien, C. Winkler, M. Dean, J.A. Nelson, M. Carrington, N.L. Michael and G.C. White 2nd (1997) HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349 1219-1220.
20. T.L. Hoffman, R.R. MacGregor, H. Burger, R. Mick, R.W. Doms and R.G. Collman (1997) CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J. Infect. Dis. 176 1093-1096.
21. M. Marmor, H.W. Sheppard, D. Donnell, S. Bozeman, C. Celum, S. Buchbinder, B. Koblin and G.R. Seage 3rd (2001) Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. J. Acquir. Immune Defic. Syndr. 27 472-481.
22. J.P. Ioannidis, T.R. O'Brien, P.S. Rosenberg, D.G. Contopoulos-Ioannidis and J.J. Goedert (1998) Genetic effects on HIV disease progression. Nat. Med. 4 536.
23. N.L. Michael, G. Chang, L.G. Louie, J.R. Mascola, D. Dondero, D.L. Birx and H.W. Sheppard (1997) The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3 338-340.
24. P.A. Zimmerman, A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vaccarezza, P.E. Kennedy, V. Kumaraswami, J.V. Giorgi, R. Detels, J. Hunter, M. Chopek, E.A. Berger, A.S. Fauci, T.B. Nutman and P.M. Murphy (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3 23-36.
25. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard and J. Sokroski (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 1135-1148.
26. F. Cocchi, A.L. DeVico, A. Garzino-Demo, A. Cara, R.C. Gallo and P. Lusso (1996) The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2 1244-1247.
27. R.F. Speck, K. Wehrly, E.J. Platt, R.E. Atchison, I.F. Charo, D. Kabat, B. Chesebro and M.A. Goldsmith (1997) Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71 7136-7139.
28. L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, C. Gerard and J. Sodroski (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384 179-183.
29. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski and W.A. Hendrickson (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393 648-659.
30. C.D. Rizzuto, R. Wyatt, N. Hernandez-Ramos, Y. Sun, P.D. Kwong, W.A. Hendrickson and J. Sodroski (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280 1949-1953.
31. R. Wyatt, P.D. Kwong, E. Desjardins, R.W. Sweet, J. Robinson, W.A. Hendrickson and J.G. Sodroski (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393 705-711.
32. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto and M. Miyano (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 739-745.
33. R.E. Atchison, J. Gosling, F.S. Monteclaro, C. Franci, L. Digilio, I.F. Charo and M.A. Goldsmith (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274 1924-1926.
34. P.D. Bieniasz, R.A. Fridell, I. Aramori, S.S. Ferguson, M.G. Caron and B.R. Cullen (1997) HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J. 16 2599-2609.
35. L. Picard, G. Simmons, C.A. Power, A. Meyer, R.A. Weiss and P.R. Clapham (1997) Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71 5003-5011.
36. J. Rucker, M. Samson, B.J. Doranz, F. Libert, J.F. Berson, Y. Yi, R.J. Smyth, R.G. Collman, C.C. Broder, G. Vassart, R.W. Doms and M. Parmentier (1996) Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87 437-446.
37. L. Wu, G. LaRosa, N. Kassam, C.J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, J.P. Moore and C.R. Mackay (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 pg120 binding and a single domain for chemokine binding. J. Exp. Med. 186 1373-1381.
38. Z. Lu, J.F. Berson, Y. Chen, J.D. Turner, T. Zhang, M. Sharron, M.H. Jenks, Z. Wang, J. Kim, J. Rucker, J.A. Hoxie, S.C. Peiper and R.W. Doms (1997) Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94 6426-6431.
39. A. Brelot, N. Heveker, O. Pleskoff, N. Sol and M. Alizon (1997) Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71 4744-4751.
40. L. Picard, D.A. Wilkinson, A. McKnight, P.W. Gray, J.A. Hoxie, P.R. Clapham and R.A. Weiss (1997) Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. Virology 231 105-111.
41. S. Potempa, L. Picard, J.D. Reeves, D. Wilkinson, R.A. Weiss and S.J. Talbot (1997) CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry. J. Virol. 71 4419-4424.
42. J.D. Reeves, N. Heveker, A. Brelot, M. Alizon, P.R. Clapham and L. Picard (1998) The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2. J. Gen. Virol. 79 1793-1799.
43. R.W. Doms (2000) Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276 229-237.
44. K. Tokunaga, M.L. Greenberg, M.A. Morse, R.I. Cumming, H.K. Lyerly and B.R. Cullen (2001) Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J. Virol. 75 6776-6785.
45. G. Simmons, J.D. Reeves, A. McKnight, N. Dejucq, S. Hibbitts, C.A. Power, E. Aarons, D. Schols, E. De Clercq, A.E. Proudfoot and P.R. Clapham (1998) CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J. Virol. 72 8453-8457.
46. G. Simmons, D. Wilkinson, J.D. Reeves, M.T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P.W. Gray, R.A. Weiss and P.R. Clapham (1996) Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70 8355-8360.
47. Y. Yi, S. Rana, J.D. Turner, N. Gaddis and R.G. Collman (1998) CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72 772-777.
48. F. Baribaud, T.G. Edwards, M. Sharron, A. Brelot, N. Heveker, K. Price, F. Mortari, M. Alizon, M. Tsang and R.W. Doms (2001) Antigenically distinct conformations of CXCR4. J. Virol. 75 8957-8967.
49. B. Lee, M. Sharron, C. Blanpain, B.J. Doranz, J. Vakili, P. Setoh, E. Berg, G. Liu, H.R. Guy, S.R. Durell, M. Parmentier, C.N. Chang, K. Price, M. Tsang and R.W. Doms (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274 9617-9626.
50. M. Farzan, T. Mirzabekov, P. Kolchinksy, R. Wyatt, M. Cayabyab, N.P. Gerard, C. Gerard, J. Sodroski and H. Choe (1999) Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 667-676.
51. G. Alkhatib, M. Locati, P.E. Kennedy, P.M. Murphy and E.A. Berger (1997) HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 234 340-348.
52. J. Gosling, F.S. Monteclaro, R.E. Atchison, H. Arai, C.L. Tsou, M.A. Goldsmith and I.F. Charo (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94 5061-5066.
53. A. Kinter, J. Arthos, C. Cicala and A.S. Fauci (2000) Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol. Rev. 177 88-98.
54. A. Dolei, A. Biolchini, C. Serra, S. Curreli, E. Gomes and F. Dianzani (1998) Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. AIDS 12 183-190.
55. C.J. Gordon, M.A. Muesing, A.E. Proudfoot, C.A. Power, J.P. Moore and A. Trkola (1999) Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 73 684-694.
56. A. Kinter, A. Catanzaro, J. Monaco, M. Ruiz, J. Justement, S. Moir, J. Arthos, A. Oliva, L. Ehler, S. Mizell, R. Jackson, M. Ostrowski, J. Hoxie, R. Offord and A.S. Fauci (1998) CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95 11880-11885.
57. A. Trkola, C. Gordon, J. Matthews, E. Maxwell, T. Ketas, L. Czaplewski, A.E. Proudfoot and J.P. Moore (1999) The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73 6370-6379.
58. J. Arthos, A. Rubbert, R.L. Rabin, C. Cicala, E. Machado, K. Wildt, M. Hanbach, T.D. Steenbeke, R. Swofford, J.M. Farber and A.S. Fauci (2000) CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J. Virol. 74 6418-6424.
59. B. Chackerian, E.M. Long, P.A. Luciw and J. Overbaugh (1997) Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71 3932-3939.
60. K. Mori, D.J. Ringler and R.C. Desrosiers (1993) Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J. Virol. 67 2807-2814.
61. H. Schmidtmayerova, M. Alfano, G. Nuovo and M. Bukrinsky (1998) Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72 4633-4642.